This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2009 by University of South Florida.
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborator:
AstraZeneca
Information provided by:
University of South Florida
ClinicalTrials.gov Identifier:
NCT00579280
First received: December 18, 2007
Last updated: January 13, 2011
Last verified: February 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2010
  Estimated Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)